Suchergebnisse - "Fountaine, Robert J"

PubPharm (17)

1

Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19

enthalten in: The New England journal of medicine | 2024

von Hammond, J. | Fountaine, R. | Yunis, C. | +10

2

Characterization of adverse joint outcomes in patients with osteoarthritis treated with subcutaneous tanezumab

enthalten in: Osteoarthritis and cartilage | 2023

von Carrino, J. | McAlindon, T. | Schnitzer, T. | +10

3

Inter-Reader Consistency and Exclusionary Findings During Radiographic Screening for Phase 3 Trials of Tanezumab in Patients With Osteoarthritis

enthalten in: Osteoarthritis imaging | 2022

von Guermazi, A. | Roemer, F. | Kompel, A. | +10

4

Observed efficacy and clinically important improvements in participants with osteoarthritis treated with subcutaneous tanezumab : results from a 56-week randomized NSAID-controlled study

enthalten in: Arthritis research & therapy | 2022

von Neogi, T. | Hunter, D. | Churchill, M. | +10

5

Observed efficacy and clinically important improvements in participants with osteoarthritis treated with subcutaneous tanezumab: results from a 56-week randomized NSAID-controlled study

enthalten in: Arthritis Research & Therapy | 2022

von Neogi, T. | Hunter, D. | Churchill, M. | +10

6

Observed efficacy and clinically important improvements in participants with osteoarthritis treated with subcutaneous tanezumab: results from a 56-week randomized NSAID-controlled study

enthalten in: Arthritis Research & Therapy | 2022

von Neogi, T. | Hunter, D. | Churchill, M. | +10

7

Neurological safety of subcutaneous tanezumab versus NSAID in patients with osteoarthritis

enthalten in: Journal of the neurological sciences | 2022

von Brown, M. | Sandroni, P. | Low, P. | +7

8

Long-Term Safety and Efficacy of Subcutaneous Tanezumab Versus Nonsteroidal Antiinflammatory Drugs for Hip or Knee Osteoarthritis : A Randomized Trial

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2021

von Hochberg, M. | Carrino, J. | Schnitzer, T. | +11

9

Long‐Term Safety and Efficacy of Subcutaneous Tanezumab Versus Nonsteroidal Antiinflammatory Drugs for Hip or Knee Osteoarthritis : A Randomized Trial

enthalten in: Arthritis & Rheumatology | 2021

von Hochberg, M. | Carrino, J. | Schnitzer, T. | +11

10

Safety and efficacy of subcutaneous tanezumab in patients with knee or hip osteoarthritis

enthalten in: Journal of pain research | 2018

von Birbara, C. | Dabezies, E. | Burr, A. | +6